<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1310.html">Part 1310
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1310.11  Reinstatement of exemption for drug products
                            </h3>
                            <p class="depth1"><em>(a)</em> The Administrator has reinstated the exemption for the drug  products listed in paragraph (e) of this section from application of  sections 302, 303, 310, 1007, and 1008 of the Act (21 U.S.C. 822-823,  830, and 957-958), to the extent described in paragraphs (b), (c), and  (d) of this section.</p><p class="depth1"><em>(b)</em> No reinstated exemption granted pursuant to 1310.10 affects the  criminal liability for illegal possession or distribution of listed  chemicals contained in the exempt drug product.</p><p class="depth1"><em>(c)</em> Changes in exempt drug product compositions: Any change in the  quantitative or qualitative composition, trade name or other designation  of an exempt drug product listed in paragraph (d) requires a new  application for reinstatement of the exemption.</p><p class="depth1"><em>(d)</em> The following drug products, in the form and quantity listed in  the application submitted (indicated as the ``date'') are designated as  reinstated exempt drug products for the purposes set forth in this  section:</p><p class="depth2">Exempt Drug Products ----------------------------------------------------------------------------------------------------------------</p><p class="depth2">Supplier                      Product name                 Form                     Date ---------------------------------------------------------------------------------------------------------------- [Reserved]...........................  .......................  .......................  ....................... ----------------------------------------------------------------------------------------------------------------   [60 FR 32462, June 22, 1995]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
